share_log

Helius Medical Technologies Announces Reimbursement Determination For PoNs Mouthpiece Set At $2,963.30 On Lump Sum Payment To Be Challenged By Co; Disagrees With CMS' Methods, Pricing & Deferral For Determining Payment Rates For PoNs Mouthpiece & Pons...

Helius Medical Technologies Announces Reimbursement Determination For PoNs Mouthpiece Set At $2,963.30 On Lump Sum Payment To Be Challenged By Co; Disagrees With CMS' Methods, Pricing & Deferral For Determining Payment Rates For PoNs Mouthpiece & Pons...

helius medical technologies宣佈,PoNs口腔裝置套裝的報銷確定金額爲$2,963.30,將由公司提出總額支付挑戰;不同意康哲藥業的方法、定價和推遲確定PoNs口腔裝置和Pons的支付費率。
Benzinga ·  10/14 23:06

Helius Medical Technologies Announces Reimbursement Determination For PoNs Mouthpiece Set At $2,963.30 On Lump Sum Payment To Be Challenged By Co; Disagrees With CMS' Methods, Pricing & Deferral For Determining Payment Rates For PoNs Mouthpiece & Pons Controller

Helius Medical Technologies宣佈一次性支付2963.30美元的PonS喉舌套裝的報銷決定,將受到公司的質疑;不同意CMS確定PonS喉舌和Pons控制器付款率的方法、定價和延期付款方法、定價和延期付款

-- Reimbursement Determination for the PoNS Mouthpiece (HCPCS code A4594) set at $2,963.30 on Lump Sum Payment to be challenged by Helius --

— PonS Mouthpiece(HCPCS 代碼 A4594)的報銷決定定爲一次性付款 2,963.30 美元,將由 Helius 提出質疑 —

-- National Reimbursement Payment Determination from CMS for its PoNS Controller Deferred to the Next Cycle --

--CMS爲其PonS控制員作出的國家補償金付款決定推遲到下一個週期——

NEWTOWN, Pa., Oct. 14, 2024 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ:HSDT) ("Helius" or the "Company"), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, today announced that the Centers for Medicare & Medicaid Services (CMS) posted final Medicare Durable Medical Equipment, Prosthetics, Orthotics, and Supplies fee schedule payment rates for the PoNS Mouthpiece (HCPCS code A4594) at $2,963.30 to be implemented January 1, 2025 and deferred final national determination of the payment rate for the PoNS Controller (HCPCS Code A4593) to the next payment cycle.

賓夕法尼亞州紐敦,2024年10月14日(GLOBE NEWSWIRE)——專注於爲平衡和步態缺陷提供新型治療性神經調節方法的神經科技公司Helius Medical Technologies, Inc.(納斯達克股票代碼:HSDT)(「Helius」 或 「公司」)今天宣佈,醫療保險和醫療補助服務中心(CMS)發佈了最終的醫療保險耐用醫療設備假肢,PonS Mouthpiece(HCPCS 代碼 A4594)的費用表付款率爲2,963.30美元,將於2025年1月1日起實施,並推遲了全國對該問題的最終決定PonS 控制器(HCPCS 代碼 A4593)到下一個付款週期的付款費率。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論